UTAH MEDICAL PRODUCTS INC (UTMD) › Cash & EquivalentsUTAH MEDICAL PRODUCTS INC (UTMD) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $97.0K2009: $410.0K2010: $3.82M2011: $6.53M2012: $8.87M2013: $14.39M2014: $19.27M2015: $23.28M2016: $26.30M2017: $39.88M2018: $51.11M2019: $42.79M2020: $51.59M2021: $60.97M2022: $75.05M2023: $92.87M2024: $82.98M2025: $85.76M$85.76M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$85.76M+3.4%2024$82.98M-10.7%2023$92.87M+23.7%2022$75.05M+23.1%2021$60.97M+18.2%2020$51.59M+20.6%2019$42.79M-16.3%2018$51.11M+28.2%2017$39.88M+51.6%2016$26.30M+13.0%2015$23.28M+20.8%2014$19.27M+33.9%2013$14.39M+62.3%2012$8.87M+35.8%2011$6.53M+71.1%2010$3.82M+831.2%2009$410.0K+322.7%2008$97.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share